Shop
Cart Details

Cosentyx Snrdy 300Mg Dose-2Pen

  • Manufacturer Name : Novartis
  • MFG # : 00078063941
  • NDC : 00078063941
  • Distributor Name : McKesson - SAGEBRUSH
PID UOM Price Qty
350693 UN Register For Member Price
350770 1/EA Register For Member Price
Register For Member Price

 

Product Information

NDC Package Code0078-0639-41
Proprietary NameCosentyx
Non-Proprietary NameSecukinumab
Package2 mL in 1 CARTON (0078-0639-41)
Dosage FormINJECTION
RouteSUBCUTANEOUS
Active Ingredient Strength150
Active Ingredient Unitsmg/mL
Substance NameSECUKINUMAB

Description

1.1     Plaque Psoriasis

COSENTYX® is indicated for the treatment of moderate to severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy.

1.2     Psoriatic Arthritis

COSENTYX is indicated for the treatment of active psoriatic arthritis (PsA) in patients 2 years of age and older.

1.3     Ankylosing Spondylitis

COSENTYX is indicated for the treatment of adult patients with active ankylosing spondylitis (AS).

1.4     Non-Radiographic Axial Spondyloarthritis

COSENTYX is indicated for the treatment of adult patients with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation.

1.5     Enthesitis-Related Arthritis

COSENTYX is indicated for the treatment of active enthesitis-related arthritis (ERA) in pediatric patients 4 years of age and older.

Frequently Asked Questions(FAQs)

The cost of Cosentyx Snrdy 300Mg Dose-2Pen is $0.00 .
Cosentyx Snrdy 300Mg Dose-2Pen is manufactured by Novartis.
Read More

Subscribe to Our Newsletter